Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial

Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial - E4599

Published:2005-06 Issue:16_suppl Volume:23 Page:LBA4-LBA4
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Sandler A. B.¹,Gray R.¹,Brahmer J.¹,Dowlati A.¹,Schiller J. H.¹,Perry M. C.¹,Johnson D. H.¹

Affiliation:

1. Vanderbilt-Ingram Cancer Ctr, Nashville, TN; Dana-Farber Cancer Ctr, Boston, MA; Johns Hopkins Univ, Baltimore, MD; Case-Western Univ Hospitals, Cleveland, OH; Univ of Wisconsin, Madison, WI; Univ of Missouri-Ellis Fischel Cancer Ctr, Columbia, MO

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2005.23.16_suppl.lba4

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Influence of Residual or Recurrent Disease on Bevacizumab Treatment Efficacy in Ovarian Cancer: Current Evidence and Future Perspectives;Cancers;2024-03-05

2. The Clinical Impact of Vascular Endothelial Growth Factor/Receptor (VEGF/R) Inhibitors on Voice;Case Reports in Otolaryngology;2023-04-01

3. Invasive cervical cancer;DiSaia and Creasman Clinical Gynecologic Oncology;2023

4. Local Treatment of Non-small Cell Lung Cancer with a Spray-Dried Bevacizumab Formulation;AAPS PharmSciTech;2021-08-31

5. Invasive Cervical Cancer;Clinical Gynecologic Oncology;2018